Cargando…

Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells

The psychoactive component in cannabis, delta‐9‐tetrahydrocannabinol, can restrict fetal growth and development. Delta‐9‐tetrahydrocannabinol has been shown to negatively impact cellular proliferation and target organelles like the mitochondria resulting in reduced cellular respiration. In the place...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, O’Llenecia S., Ragos, Rehginald, Gurm, Harmeet, Lapierre, Mariah, May, Linda L., Raha, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336740/
https://www.ncbi.nlm.nih.gov/pubmed/32628362
http://dx.doi.org/10.14814/phy2.14476
_version_ 1783554379388813312
author Walker, O’Llenecia S.
Ragos, Rehginald
Gurm, Harmeet
Lapierre, Mariah
May, Linda L.
Raha, Sandeep
author_facet Walker, O’Llenecia S.
Ragos, Rehginald
Gurm, Harmeet
Lapierre, Mariah
May, Linda L.
Raha, Sandeep
author_sort Walker, O’Llenecia S.
collection PubMed
description The psychoactive component in cannabis, delta‐9‐tetrahydrocannabinol, can restrict fetal growth and development. Delta‐9‐tetrahydrocannabinol has been shown to negatively impact cellular proliferation and target organelles like the mitochondria resulting in reduced cellular respiration. In the placenta, mitochondrial dysfunction leading to oxidative stress prevents proper placental development and function. A key element of placental development is the proliferation and fusion of cytotrophoblasts to form the syncytium that comprises the materno‐fetal interface. The impact of delta‐9‐tetrahydrocannabinol on this process is not well understood. To elucidate the nature of the mitochondrial dysfunction and its consequences on trophoblast fusion, we treated undifferentiated and differentiated BeWo human trophoblast cells, with 20 µM delta‐9‐tetrahydrocannabinol for 48 hr. At this concentration, delta‐9‐tetrahydrocannabinol on BeWo cells reduced the expression of markers involved in syncytialization and mitochondrial dynamics, but had no effect on cell viability. Delta‐9‐tetrahydrocannabinol significantly attenuated the process of syncytialization and induced oxidative stress responses in BeWo cells. Importantly, delta‐9‐tetrahydrocannabinol also caused a reduction in the secretion of human chorionic gonadotropin and the production of human placental lactogen and insulin growth factor 2, three hormones known to be important in facilitating fetal growth. Furthermore, we also demonstrate that delta‐9‐tetrahydrocannabinol attenuated mitochondrial respiration, depleted adenosine triphosphate, and reduced mitochondrial membrane potential. These changes were also associated with an increase in cellular reactive oxygen species, and the expression of stress responsive chaperones, HSP60 and HSP70. These findings have important implications for understanding the role of delta‐9‐tetrahydrocannabinol‐induced mitochondrial injury and the role this might play in compromising human pregnancies.
format Online
Article
Text
id pubmed-7336740
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73367402020-07-08 Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells Walker, O’Llenecia S. Ragos, Rehginald Gurm, Harmeet Lapierre, Mariah May, Linda L. Raha, Sandeep Physiol Rep Original Articles The psychoactive component in cannabis, delta‐9‐tetrahydrocannabinol, can restrict fetal growth and development. Delta‐9‐tetrahydrocannabinol has been shown to negatively impact cellular proliferation and target organelles like the mitochondria resulting in reduced cellular respiration. In the placenta, mitochondrial dysfunction leading to oxidative stress prevents proper placental development and function. A key element of placental development is the proliferation and fusion of cytotrophoblasts to form the syncytium that comprises the materno‐fetal interface. The impact of delta‐9‐tetrahydrocannabinol on this process is not well understood. To elucidate the nature of the mitochondrial dysfunction and its consequences on trophoblast fusion, we treated undifferentiated and differentiated BeWo human trophoblast cells, with 20 µM delta‐9‐tetrahydrocannabinol for 48 hr. At this concentration, delta‐9‐tetrahydrocannabinol on BeWo cells reduced the expression of markers involved in syncytialization and mitochondrial dynamics, but had no effect on cell viability. Delta‐9‐tetrahydrocannabinol significantly attenuated the process of syncytialization and induced oxidative stress responses in BeWo cells. Importantly, delta‐9‐tetrahydrocannabinol also caused a reduction in the secretion of human chorionic gonadotropin and the production of human placental lactogen and insulin growth factor 2, three hormones known to be important in facilitating fetal growth. Furthermore, we also demonstrate that delta‐9‐tetrahydrocannabinol attenuated mitochondrial respiration, depleted adenosine triphosphate, and reduced mitochondrial membrane potential. These changes were also associated with an increase in cellular reactive oxygen species, and the expression of stress responsive chaperones, HSP60 and HSP70. These findings have important implications for understanding the role of delta‐9‐tetrahydrocannabinol‐induced mitochondrial injury and the role this might play in compromising human pregnancies. John Wiley and Sons Inc. 2020-07-06 /pmc/articles/PMC7336740/ /pubmed/32628362 http://dx.doi.org/10.14814/phy2.14476 Text en © 2020 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Walker, O’Llenecia S.
Ragos, Rehginald
Gurm, Harmeet
Lapierre, Mariah
May, Linda L.
Raha, Sandeep
Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells
title Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells
title_full Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells
title_fullStr Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells
title_full_unstemmed Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells
title_short Delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells
title_sort delta‐9‐tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental bewo cells
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336740/
https://www.ncbi.nlm.nih.gov/pubmed/32628362
http://dx.doi.org/10.14814/phy2.14476
work_keys_str_mv AT walkerollenecias delta9tetrahydrocannabinoldisruptsmitochondrialfunctionandattenuatessyncytializationinhumanplacentalbewocells
AT ragosrehginald delta9tetrahydrocannabinoldisruptsmitochondrialfunctionandattenuatessyncytializationinhumanplacentalbewocells
AT gurmharmeet delta9tetrahydrocannabinoldisruptsmitochondrialfunctionandattenuatessyncytializationinhumanplacentalbewocells
AT lapierremariah delta9tetrahydrocannabinoldisruptsmitochondrialfunctionandattenuatessyncytializationinhumanplacentalbewocells
AT maylindal delta9tetrahydrocannabinoldisruptsmitochondrialfunctionandattenuatessyncytializationinhumanplacentalbewocells
AT rahasandeep delta9tetrahydrocannabinoldisruptsmitochondrialfunctionandattenuatessyncytializationinhumanplacentalbewocells